[go: up one dir, main page]

 
 
Sign in to use this feature.

Years

Between: -

Subjects

remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline

Journals

remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline

Article Types

Countries / Regions

remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline

Search Results (22,207)

Search Parameters:
Keywords = injectable

Order results
Result details
Results per page
Select all
Export citation of selected articles as:
16 pages, 426 KiB  
Review
Intravesical Botulin Toxin-A Injections for Neurogenic Bladder Dysfunction in Children: Summary Update on Last 10 Years of Research
by Andrea Zulli, Virginia Carletti, Alberto Mantovani, Maria Angela Cerruto and Luca Giacomello
Toxins 2024, 16(8), 339; https://doi.org/10.3390/toxins16080339 - 1 Aug 2024
Viewed by 402
Abstract
Neurogenic bladder dysfunction (NB) represents a challenge in pediatric urology. Intravesical botulin toxin-A (BTX-A) bladder injection is part of the armamentarium for the treatment of this condition, usually after failed first-line medical strategies and before the escalation to more invasive options such as [...] Read more.
Neurogenic bladder dysfunction (NB) represents a challenge in pediatric urology. Intravesical botulin toxin-A (BTX-A) bladder injection is part of the armamentarium for the treatment of this condition, usually after failed first-line medical strategies and before the escalation to more invasive options such as neuromodulation or augmented cystoplasty in severe cases. However, there is still a lack of consensus about the appropriate treatment modality for the pediatric population. A review of the last 10 years’ research was performed on the PubMed database by two authors. Articles doubly selected and meeting the inclusion criteria were collected and analyzed for their study type, demographics, neurological disease(s) at diagnosis, BTX-A treatment modality and duration, previous treatment, clinical and urodynamic parameters, adverse events, outcomes, and follow-ups. A total of 285 studies were initially selected, 16 of which matched the inclusion criteria. A cohort of 630 patients was treated with BTX-A at a median age of 9.7 years, 40% of which had a diagnosis of myelomeningocele. The results of the selected publications show the overall efficacy and safety of BTX-A injections in children and confirmed BTX-A as a valuable strategy for NB treatment in pediatric population. Nevertheless, up to now, the literature on this topic offers scarce uniformity among the published series and poor protocol standardization. Full article
Show Figures

Figure 1

Figure 1
<p>Prisma flow chart: study selection.</p>
Full article ">
15 pages, 2572 KiB  
Article
Synthetic Amphipathic Helical Peptide L-37pA Ameliorates the Development of Acute Respiratory Distress Syndrome (ARDS) and ARDS-Induced Pulmonary Fibrosis in Mice
by Aleksandr S. Chernov, Georgii B. Telegin, Alexey N. Minakov, Vitaly A. Kazakov, Maksim V. Rodionov, Viktor A. Palikov, Anna A. Kudriaeva and Alexey A. Belogurov
Int. J. Mol. Sci. 2024, 25(15), 8384; https://doi.org/10.3390/ijms25158384 - 1 Aug 2024
Viewed by 355
Abstract
In this study, we evaluated the ability of the synthetic amphipathic helical peptide (SAHP), L-37pA, which mediates pathogen recognition and innate immune responses, to treat acute respiratory distress syndrome (ARDS) accompanied by diffuse alveolar damage (DAD) and chronic pulmonary fibrosis (PF). For the [...] Read more.
In this study, we evaluated the ability of the synthetic amphipathic helical peptide (SAHP), L-37pA, which mediates pathogen recognition and innate immune responses, to treat acute respiratory distress syndrome (ARDS) accompanied by diffuse alveolar damage (DAD) and chronic pulmonary fibrosis (PF). For the modeling of ARDS/DAD, male ICR mice were used. Intrabronchial instillation (IB) of 200 µL of inflammatory agents was performed by an intravenous catheter 20 G into the left lung lobe only, leaving the right lobe unaffected. Intravenous injections (IVs) of L-37pA, dexamethasone (DEX) and physiological saline (saline) were used as therapies for ARDS/DAD. L37pA inhibited the circulating levels of inflammatory cytokines, such as IL-8, TNFα, IL1α, IL4, IL5, IL6, IL9 and IL10, by 75–95%. In all cases, the computed tomography (CT) data indicate that L-37pA reduced lung density faster to −335 ± 23 Hounsfield units (HU) on day 7 than with DEX and saline, to −105 ± 29 HU and −23 ± 11 HU, respectively. The results of functional tests showed that L-37pA treatment 6 h after ARDS/DAD initiation resulted in a more rapid improvement in the physiological respiratory lung by 30–45% functions compared with the comparison drugs. Our data suggest that synthetic amphipathic helical peptide L-37pA blocked a cytokine storm, inhibited acute and chronic pulmonary inflammation, prevented fibrosis development and improved physiological respiratory lung function in the ARDS/DAD mouse model. We concluded that a therapeutic strategy using SAHPs targeting SR-B receptors is a potential novel effective treatment for inflammation-induced ARDS, DAD and lung fibrosis of various etiologies. Full article
(This article belongs to the Section Molecular Pathology, Diagnostics, and Therapeutics)
Show Figures

Figure 1

Figure 1
<p>Lung analysis: (<b>A</b>) Three-dimensional CT image reconstruction (ventral view) of the left lung using the contrast agent Omnipaque 240. (<b>B</b>) Intact left lung histology analysis (magnification 50× and 200×); black arrows indicate normal alveoli.</p>
Full article ">Figure 2
<p>Levels of serum chemokines and cytokine in ICR mice with ARDS/DAD after administration of saline, DEX or L37pA. Asterisks denote statistically significant differences in saline (red) or dexamethasone (orange) test groups. Bars represent median, interquartile range with standard deviation (<span class="html-italic">p</span>-value: * &lt; 0.05).</p>
Full article ">Figure 3
<p>Treatment by L37pA induces fast recovery of the injured lung in ICR mice with ARDS/DAD. Density and volume of the <b>left</b> (<b>panel A</b>) and <b>right</b> (<b>panel B</b>) lung tissues in the experimental groups with ARDS/DAD. Asterisks denote statistically significant differences in saline (red) and dexamethasone (orange) test groups. Bars represent median, interquartile range with standard deviation (<span class="html-italic">p</span>-value: * &lt; 0.05).</p>
Full article ">Figure 4
<p>Measurement of respiratory function in mice with ARDS/DAD after administration by saline, DEX and L37pA. Respiratory rate (<b>panel A</b>); tidal volume (<b>panel B</b>); maximal expiratory flow (<b>panel C</b>) and minute volume (<b>panel D</b>) were assessed on day 7, 14, 30 and 45 after LPS/GC IB instillation and IV-injected saline, DEX, L37pA or in intact animals without DAD. Asterisks denote statistically significant differences in saline (red) or dexamethasone (orange) test groups. Bars represent median, interquartile range with standard deviation (<span class="html-italic">p</span>-value: * &lt; 0.05).</p>
Full article ">Figure 5
<p>Left lung histology 7 and 45 days after ARDS/DAD treated with saline, DEX or L37pA. Results reflect a semi-quantitative analysis of lung injury in left lung. Hematoxylin/Eosin staining: left lung mononuclear infiltration (<b>panel A</b>); left lung fibrosis (Masson staining) on day 45 after ARDS/DAD initiation and Kernogan’s index (<b>panel B</b>). Statistically significant differences are indicated as *—<span class="html-italic">p</span> &lt; 0.05; **—<span class="html-italic">p</span> &lt; 0.005.</p>
Full article ">
11 pages, 1146 KiB  
Brief Report
When Implementing the Presynch-11/Ovsynch Reproductive Management Program, the Fertility of Lactating Dairy Cows Improved When They Received Timed Artificial Insemination Compared with the Inclusion of Estrus Detection
by Jaimie Marie Strickland, João Paulo Nascimento Martins, Lou Neuder and James R. Pursley
Animals 2024, 14(15), 2235; https://doi.org/10.3390/ani14152235 - 31 Jul 2024
Viewed by 441
Abstract
Artificial insemination 12 h following observed standing estrus is a standard estimate of the fertility levels of cattle. The main objective of this study was to determine if controlling ovarian development with a fertility program could alter the fertility of lactating dairy cows. [...] Read more.
Artificial insemination 12 h following observed standing estrus is a standard estimate of the fertility levels of cattle. The main objective of this study was to determine if controlling ovarian development with a fertility program could alter the fertility of lactating dairy cows. Lactating dairy cows (n = 1356) 60–66 days in milk (DIM) were randomly assigned to receive timed AI following Presynch-11/Ovsynch (Presynch-11) or a combination of estrus detection and timed AI using the Presynch-11/Ovsynch program (Estrus + TAI). Cows in standing estrus, following the first two cloprostenol sodium (CLO) injections, in the Estrus + TAI group were artificially inseminated using the AM/PM rule. Cows in this group that were not observed in standing estrus received Ovsynch and TAI beginning 11 d after the second CLO injection. Cows in the Presynch-11 group received two injections of 500 µg CLO 14 d apart but were not observed for estrus. The first GnRH (100 µg) of Ovsynch was administered 11 d following the second CLO injection. All cows in the Presynch-11-Ovsynch group received TAI following Ovsynch. Cows in this treatment were then assigned randomly to receive either CLO or dinoprost 7 d following the first GnRH of Ovsynch. The final GnRH of Ovsynch was administered 56 h later and TAI 16 h after the final GnRH. Pregnancies/AI (P/AI) were greater (p < 0.001) for the Presynch-11 group compared with the Estrus + TAI group (45 vs. 31%). Primiparous cows had greater fertility following observed standing estrus compared with multiparous cows. Days in milk at the first AI were greater (p < 0.01) in the Presynch-11 group vs. the Estrus + TAI group (98 vs. 80) but less variable (p < 0.01). The range of DIM at the first AI was 95 to 101 in the Presynch-11 group and 60 to 101 in the Estrus + TAI group. Within the Presynch-11 group, there were no differences in the rate of luteolysis or P/AI for the prostaglandin type at the final PGF of Ovsynch. Multiparous cows treated with Presynch-11 had >60% chance of pregnancy compared with multiparous cows receiving AI following standing estrus. In summary, lactating dairy cows receiving timed AI following the Presynch-11/Ovsynch program had improved fertility compared with a group of cows that received AI following standing estrus or, if not observed in estrus, timed AI. This comparison indicated that controlling ovarian development with GnRH and PGF positively impacted the fertility of lactating dairy cows. Full article
Show Figures

Figure 1

Figure 1
<p>Experimental design to determine the effect of timed AI only with the fertility program Presynch-11/Ovsynch (Presynch-11) vs. AI following detected estrus following both PGF<sub>2α</sub> injections within Presynch-11/Ovsynch with timed AI (TAI) utilized in cows not detected in estrus (Estrus + TAI). The 1st cloprostenol sodium (CLO) injection in both treatments was initiated between 60 and 66 days in milk (DIM). Cows in the Presynch-11 group all received TAI between 95 and 101 DIM. Estrus detection was performed in the Estrus + TAI group twice daily for the 1st period between 60 and 80 DIM and the 2nd period between 74 and 91 DIM. Cows not observed in standing estrus were treated with Ovsynch 11 days after the 2nd CLO injection and received TAI between 95 and 101 DIM. Cows in the Presynch-11 group were randomly divided into two groups at time of PGF<sub>2α</sub> of Ovsynch and received either 500 µg of CLO or 25 mg of dinoprost tromethamine (DINO). Blood samples were collected at time of CLO or DINO and at time of final GnRH of Ovsynch for determination of progesterone.</p>
Full article ">Figure 2
<p>Effect of timed AI only with the fertility program Presynch-11/Ovsynch (Presynch-11; green bar) vs. AI following detected estrus following both PGF<sub>2α</sub> injections within Presynch-11/Ovsynch with timed AI (TAI) utilized in cows not detected in estrus (Estrus + TAI; maroon bar) on P/AI. Approximately 24% of the Estrus + TAI group were not observed in standing estrus between 60 and 91 DIM and received TAI.</p>
Full article ">Figure 3
<p>Effect of timed AI only with the fertility program Presynch-11/Ovsynch (Presynch-11; green bars) vs. AI following detected estrus following both PGF<sub>2α</sub> injections within Presynch-11/Ovsynch with timed AI (TAI) utilized in cows not detected in estrus (Estrus + TAI; maroon bars) on P/AI in first, second, and third + parity lactating dairy cows. Approximately 24% of the Estrus + TAI group were not observed in standing estrus between 60 and 91 DIM and received TAI.</p>
Full article ">Figure 4
<p>Comparison of P/AI within cows in the Estrus + TAI group for observed standing estrus after first cloprostenol treatment (CLO; green bars) between 60 and 66 days in milk (DIM), after second CLO treatment (blue bars) between 74 and 91 DIM, and cows that were not observed in standing estrus and received TAI following Ovsynch (maroon bars) between 95 and 101 DIM for parities one, two, and three+.</p>
Full article ">Figure 5
<p>Effect of timed AI only with the fertility program Presynch-11/Ovsynch (Presynch-11; green bar) in cows with luteolysis (&lt;0.5 ng/mL at time of final GnRH of Ovsynch) vs. AI following detected estrus after the first two CLO treatments in the Estrus + TAI group (maroon bar).</p>
Full article ">
9 pages, 1205 KiB  
Article
Utilization of Matrix Effect for Enhancing Resolution in Cation Exchange Chromatography
by Boglárka Páll, Róbert Kormány and Krisztián Horváth
Molecules 2024, 29(15), 3637; https://doi.org/10.3390/molecules29153637 - 31 Jul 2024
Viewed by 465
Abstract
In ion chromatography studies, the matrix effect of other inorganic ions present in the sample is a well-known phenomenon. In this work, the behavior of inorganic and organic ions was studied in a system overloaded with ammonium ions. The ammonium ions came from [...] Read more.
In ion chromatography studies, the matrix effect of other inorganic ions present in the sample is a well-known phenomenon. In this work, the behavior of inorganic and organic ions was studied in a system overloaded with ammonium ions. The ammonium ions came from a solution of ammonium hydroxide in various concentrations (0.25–1.25%). In this system, which was significantly overloaded with ammonium ions, the behavior of three ions were tested (lithium, tris, and sodium cations). The measurements were performed at different eluent concentrations (6–17 mM), chromatographic column temperatures (25–40 °C), and injected volumes (15–40 µL). The retention times of sodium and lithium ions increased with increasing amounts of injected ammonium, while tris remained essentially unchanged, indicating that the resolution of these ions can be influenced by varying the concentration of the matrix. The results suggested that the observed effect was due to a combination of the pH change caused by the injected matrix, the dissociation of tris ions, the dissociation of the carbocylic ion-exchange groups of stationary phase, the change in buffer capacity, and the amount of ammonium ion introduced. It has been shown that in a well-designed experiment, the addition of ammonium hydroxide to the sample at concentrations greater than 1% can improve the efficiency of organic and inorganic cation separation. It was found that 8 mM methanesulfonic acid eluent, 30 °C, 1% ammonium hydroxide matrix concentration, and 25 µL injection were optimal for the baseline separation of tris and sodium ions on the high-capacity Dionex CS16 column. These ions could not be separated on this column without the presence of the ammonium matrix. Full article
Show Figures

Figure 1

Figure 1
<p>The retention times of sodium ion by varying the ammonium hydroxide solution concentration and the eluent (methanesulfonic acid, MSA) concentration.</p>
Full article ">Figure 2
<p>Peaks of sodium cations at different levels of ammonium hydroxide matrix eluted with 17 mM methansulfonic eluent at 40 °C.</p>
Full article ">Figure 3
<p>(<b>A</b>) Change in the theoretical plate number values of sodium ion by varying the ammonium hydroxide solution concentration and the eluent (MSA) concentration; (<b>B</b>) change in symmetry factor values of the sodium ion by varying the ammonium hydroxide solution concentration and the eluent (MSA) concentration.</p>
Full article ">Figure 4
<p>Change in retention time of lithium (blue), tris (gray), and sodium ions (orange) by varying the ammonium hydroxide solution concentration at 25 °C (<b>A</b>), 30 °C (<b>B</b>), and 40 °C (<b>C</b>).</p>
Full article ">Figure 5
<p>Change in retention time of lithium (blue), tris (gray), and sodium ions (orange) by varying the ammonium hydroxide solution concentration by injecting 15 <math display="inline"><semantics> <mi mathvariant="sans-serif">µ</mi> </semantics></math>L (<b>A</b>), 25 <math display="inline"><semantics> <mi mathvariant="sans-serif">µ</mi> </semantics></math>L (<b>B</b>), and 40 <math display="inline"><semantics> <mi mathvariant="sans-serif">µ</mi> </semantics></math>L (<b>C</b>).</p>
Full article ">Figure 6
<p>Parameters affected by the alkaline matrix: buffer capacity of injected NH<sub>4</sub>OH matrix (at 1.25%). Orange: molar fraction of dissociated (neutral) NH<sub>3</sub>; green: molar fraction of protonated (cationic) tris; red: relative eluent strength; dashed purple: relative ion-exchange capacity (assumed pKa: 2.5).</p>
Full article ">Figure 7
<p>Effect of increasing ammonium hydroxide concentration on the resolution between sodium and tris.</p>
Full article ">
17 pages, 7186 KiB  
Article
Integration of Steam Recovered from Molten Salts in a Solar Integrated Combined Cycle
by Paula Iglesias-Varela, Pedro García-Regodeseves, Juan de-la-Cruz-Fernández and Andrés Meana-Fernández
Sustainability 2024, 16(15), 6566; https://doi.org/10.3390/su16156566 - 31 Jul 2024
Viewed by 440
Abstract
In the current context of the energy transition, Integrated Solar Combined Cycle (ISCC) power plants are an alternative that are able to reduce carbon emissions from combined cycle (CC) power plants. In addition, the coupling to an energy storage system based on molten [...] Read more.
In the current context of the energy transition, Integrated Solar Combined Cycle (ISCC) power plants are an alternative that are able to reduce carbon emissions from combined cycle (CC) power plants. In addition, the coupling to an energy storage system based on molten salts benefits hybridization, allowing the energy surplus to be to stored to cover peaks in energy demand. Because it is a recent technology, the determination of the optimal injection points for the solar-generated steam into the combined cycle is a critical issue. In this work, a thermodynamic model of a hybrid natural gas and solar thermal CC power plant has been developed using Thermoflex to analyze the integration effects in terms of efficiency and power. For all the steam injection candidate positions, the effects of ‘power boosting’ and ‘fuel saving’ operation modes have been simulated, considering operation conditions that are compatible with the useful range of molten salts. The results show that injection of steam at the high-pressure line before the steam turbine increases the cycle’s gross efficiency with respect to the reference case, estimating a reduction of carbon emissions of 6696 kg/h in the ‘fuel saving’ mode and an increase in gross power of 14.4 MW in the ‘power boosting’ mode. Hence, adapting current combined cycles for hybridization with solar power is a viable solution in the transition period towards more sustainable energy sources. Full article
(This article belongs to the Section Energy Sustainability)
Show Figures

Figure 1

Figure 1
<p>Scheme of the reference case study power plant.</p>
Full article ">Figure 2
<p>Steam injection integration alternatives.</p>
Full article ">Figure 3
<p>Thermoflow model of the reference combined cycle.</p>
Full article ">Figure 4
<p>Steam lines coupling to the solar field.</p>
Full article ">Figure 5
<p>T-Q diagram of the reference combined cycle.</p>
Full article ">Figure 6
<p>Power boosting integration mode.</p>
Full article ">Figure 7
<p>Fuel saving integration mode.</p>
Full article ">Figure 8
<p>Temperature–heat transfer diagrams of alternative A, (<b>a</b>) A1—power boosting; (<b>b</b>) A2—fuel saving.</p>
Full article ">
15 pages, 912 KiB  
Article
Schizophrenia and Heart Health: Are Antipsychotics a Friend or Foe?
by Minodora Andor, Liana Dehelean, Diana Aurora Arnăutu, Marioara Nicula Neagu, Daciana Nistor, Minodora Marinela Manea, Ana-Maria Romosan and Nilima Rajpal Kundnani
J. Pers. Med. 2024, 14(8), 814; https://doi.org/10.3390/jpm14080814 - 31 Jul 2024
Viewed by 311
Abstract
Schizophrenia is one of the most disabling of the psychiatric diseases. The Brief Psychiatric Rating Scale Extended (BRSE) is used to evaluate the severity of psychiatric symptoms. Long-acting injectable (LAI) antipsychotics are commonly used and are preferred over oral antipsychotic medications. A two-center-based [...] Read more.
Schizophrenia is one of the most disabling of the psychiatric diseases. The Brief Psychiatric Rating Scale Extended (BRSE) is used to evaluate the severity of psychiatric symptoms. Long-acting injectable (LAI) antipsychotics are commonly used and are preferred over oral antipsychotic medications. A two-center-based cross-sectional study was performed on 130 patients diagnosed with schizophrenia or schizoaffective disorder based on the International Classification of Diseases 10 criteria. We studied the relation between the development of cardiovascular risk factors and the antipsychotic medication that was administered in these patients. Our study demonstrates strong links between several cardiovascular risk factors and the duration of psychosis; the duration of the LAI antipsychotic treatment; the duration between the onset of the disease and the start of LAI antipsychotic treatment; and the use of specific LAI antipsychotic medications. Full article
Show Figures

Figure 1

Figure 1
<p>Risperidone patients have a longer duration of treatment than the rest of the patients.</p>
Full article ">Figure 2
<p>Abdominal obesity correlates positively with the duration of the disease, the time before the start of the antipsychotic treatment, and the duration of the antipsychotic treatment.</p>
Full article ">Figure 3
<p>The occurrence of hypokinetic disorders correlates positively with the duration of the disease, the time before the start of the LAI antipsychotic treatment, and the duration of the treatment.</p>
Full article ">Figure 4
<p>Valvular changes are more frequent among patients with DP and a longer pre-LAI antipsychotic duration.</p>
Full article ">
15 pages, 3632 KiB  
Article
Composites from Recycled Polypropylene and Carboxymethylcellulose with Potential Uses in the Interior Design of Vehicles
by Alina Ruxandra Caramitu, Romeo Cristian Ciobanu, Ioana Ion, Mihai Marin, Eduard-Marius Lungulescu, Virgil Marinescu, Magdalena Aflori and Adriana Mariana Bors
Polymers 2024, 16(15), 2188; https://doi.org/10.3390/polym16152188 - 31 Jul 2024
Viewed by 460
Abstract
This research investigates novel polymeric composite materials for automotive interior trim applications. The composites utilize recycled polypropylene (PPr) matrix and carboxymethylcellulose (CMC) as filler (PPr/CMC: 100/0, 95/5, and 90/10 wt.%). The materials were processed by extrusion and injection molding. Considering their intended application, [...] Read more.
This research investigates novel polymeric composite materials for automotive interior trim applications. The composites utilize recycled polypropylene (PPr) matrix and carboxymethylcellulose (CMC) as filler (PPr/CMC: 100/0, 95/5, and 90/10 wt.%). The materials were processed by extrusion and injection molding. Considering their intended application, the composites were evaluated for resistance to key climatic factors, i.e., temperature, humidity, and UV radiation. In addition, structural analyses and FTIR analyses were performed to assess potential heterogeneity and thermal stability. Following FTIR tests, the incorporation of carboxymethyl cellulose in polypropylene is confirmed by the detection of characteristic CMC bands for -OH, C=O, and C-O-C groups. The results indicate slight structural heterogeneity in the 5% and 10% CMC composites. However, no thermal distortions were observed in either the composites or the PPr matrix itself. The behavior of PPr/CMC composites under the action of the mentioned climatic factors has been assessed from the variation of dielectric characteristics with frequency. The strong polarization of CMC leads to a sharp increase in composites electrical conductivity after submersion in water for 480 h, suggesting weakening of the composite structure. After exposure to UV radiation, a sharp increase in conductivity is observed even after the first cycle (72 h) of UV radiation. Following the experimental results obtained in our study, it is recommended to use the PPr +10% CMC composite for obtaining different interior ornaments (carpets, supports, etc.). At the same time, the use of these materials also has the advantage of lightening the mass of the vehicle due to their lower density than polymers. Full article
Show Figures

Figure 1

Figure 1
<p>PPr/CMC composite material samples for dielectric tests.</p>
Full article ">Figure 2
<p>Micrographs for CMC at magnifications 1000×.</p>
Full article ">Figure 3
<p>Micrographs for PPr at magnifications (<b>a</b>) 5000× and (<b>b</b>) 20,000×.</p>
Full article ">Figure 4
<p>Micrographs for PPr + 5% CMC at magnifications (<b>a</b>) 5000× and (<b>b</b>) 20,000×.</p>
Full article ">Figure 5
<p>Micrographs for PPr + 10% CMC at magnifications (<b>a</b>) 5000× and (<b>b</b>) 20,000×.</p>
Full article ">Figure 6
<p>FTIR spectra recorded on PPr-/CMC-based composites.</p>
Full article ">Figure 7
<p>Variation of (<b>a</b>) tg δ and (<b>b</b>) σ with frequency for initial samples.</p>
Full article ">Figure 8
<p>Variation of (<b>a</b>) tg δ and (<b>b</b>) σ with frequency at temperature action.</p>
Full article ">Figure 9
<p>Variation of (<b>a</b>) tg δ and (<b>b</b>) σ with frequency with UV radiation.</p>
Full article ">
24 pages, 2991 KiB  
Article
Representing Carbon Dioxide Transport and Storage Network Investments within Power System Planning Models
by Maxwell Brown, Matthew Irish, Daniel Steinberg, Tamar Moss, Daniel P. Cherney, Travis Shultz, David Morgan, Alexander Zoelle and Thomas Schmitt
Energies 2024, 17(15), 3780; https://doi.org/10.3390/en17153780 - 31 Jul 2024
Viewed by 398
Abstract
Carbon dioxide (CO2) capture and storage (CCS) is frequently identified as a potential component to achieving a decarbonized power system at least cost; however, power system models frequently lack detailed representation of CO2 transportation, injection, and storage (CTS) infrastructure. In [...] Read more.
Carbon dioxide (CO2) capture and storage (CCS) is frequently identified as a potential component to achieving a decarbonized power system at least cost; however, power system models frequently lack detailed representation of CO2 transportation, injection, and storage (CTS) infrastructure. In this paper, we present a novel approach to explicitly represent CO2 storage potential and CTS infrastructure costs and constraints within a continental-scale power system capacity expansion model. In addition, we evaluate the sensitivity of the results to assumptions about the future costs and performance of CTS components and carbon capture technologies. We find that the quantity of CO2 captured within the power sector is relatively insensitive to the range of CTS costs explored, suggesting that the cost of CO2 capture retrofits is a more important driver of CCS implementation than the costs of transportation and storage. Finally, we demonstrate that storage and injection costs account for the predominant share of total costs associated with CTS investment and operation, suggesting that pipeline infrastructure costs have limited influence on the competitiveness of CCS. Full article
(This article belongs to the Section B3: Carbon Emission and Utilization)
Show Figures

Figure 1

Figure 1
<p>Topology of CTS pipeline investment options included in ReEDS, with (<b>a</b>) all possible inter-regional trunk pipeline routes shown in blue and (<b>b</b>) all possible spur pipeline routes between region centroids and saline aquifers in orange. All saline aquifers included as storage options in the model are shown in green. Light gray lines separate model regions.</p>
Full article ">Figure 2
<p>Estimated per-mile capital costs of refrigerated liquid CO<sub>2</sub> pipelines by length and pipe diameter. The shaded region shows the approximate emissions rate of a 1-GW Gas-CC plant operating at full capacity.</p>
Full article ">Figure 3
<p>Regional supply curves for CO<sub>2</sub> storage via injection into saline aquifers by assumed capacity factor of injection facilities. The 80% capacity factor curves (shown in black) are used to parameterize costs of injection and storage within the model. These curves do not consider CO<sub>2</sub> transport costs.</p>
Full article ">Figure 4
<p>Map of the spatial extent of saline aquifers in the conterminous US and the associated levelized cost of injection and long-term storage of CO<sub>2</sub> in each saline aquifer identified for this work, assuming 80% utilization factor. Polygons are semi-transparent to show where multiple saline aquifer basins overlap at different depths.</p>
Full article ">Figure 5
<p>Evolution of total capacity (top), primary electricity generation (middle), and total mass of CO<sub>2</sub> captured each modeled year in the <span class="html-italic">No New Policy</span> scenario and <span class="html-italic">Net Zero</span> scenarios under the explicit CTS network representation, along with their LCCTS-equivalent <span class="html-italic">legacy</span> harmonized adder counterparts and the <span>$</span>15/tonne legacy representation. Points on generation plots demarcate busbar load. Technologies categorized as other are concentrated solar power (CSP), biomass and landfill gas (Bio + LFG), and oil–gas–steam (OGS).</p>
Full article ">Figure 6
<p>Maps of CCS and CTS operation in 2050 from the <span class="html-italic">Net Zero</span> and <span class="html-italic">Net Zero</span>, <span class="html-italic">LGP</span>, <span class="html-italic">AdvCCS</span> scenarios with the detailed CTS representation and the LCCTS-equivalent harmonized adder. The pie charts are sized to show CO<sub>2</sub> captured, CO<sub>2</sub> pipelines are sized to show total CO<sub>2</sub> mass flow, and CO<sub>2</sub> saline aquifers are colored to show cumulative CO<sub>2</sub> stored. Note that no pipelines or aquifers appear in the harmonized adder maps because the model is not explicitly representing them.</p>
Full article ">Figure 7
<p>Summary of CO<sub>2</sub> capture, pipeline capacity, total annual cost of CTS infrastructure and operation, and the levelized cost of CTS in 2050 for each sensitivity. Note: The LCCTS entry for the <span>$</span>36/tonne legacy adder scenario exceeds the axis limits.</p>
Full article ">
24 pages, 24251 KiB  
Article
A New Development of Cross-Correlation-Based Flow Estimation Validated and Optimized by CFD Simulation
by Xiong Gao, Lane B. Carasik, Jamie B. Coble and J. Wesley Hines
Appl. Sci. 2024, 14(15), 6687; https://doi.org/10.3390/app14156687 - 31 Jul 2024
Viewed by 403
Abstract
The accurate measurement of mass flow rates is important in nuclear power plants. Flow meters have been invented and widely applied in several industries; however, the operating environment in advanced nuclear power plants is especially harsh due to high temperatures, high radiation, and [...] Read more.
The accurate measurement of mass flow rates is important in nuclear power plants. Flow meters have been invented and widely applied in several industries; however, the operating environment in advanced nuclear power plants is especially harsh due to high temperatures, high radiation, and potentially corrosive conditions. Traditional flow meters are largely limited to deployment at the outlet of pumps, on pipes, or in limited geometries. Cross-correlation function (CCF) flow estimation, on the other hand, can estimate the flow velocity indirectly without any specific instruments for flow measurement and in any geometry of the flow region. CCF flow estimation relies on redundant instruments, typically temperature sensors, in series in the direction of flow. One challenge for CCF flow estimation is that the accuracy of the flow measurement is mainly determined by inherent, common local process variation across the sensors, which may be small compared to the uncorrelated measurement noise. To differentiate the process variations from the uncorrelated noise, this research implements periodic fluid injection at a different temperature than the bulk fluid before the temperature sensors to amplify process variation. The feasibility and accuracy of this method are investigated through flow loop experiments and Computational Fluid Dynamics (CFD) simulations. This paper focuses on a CFD simulation model to verify the previous experimental results and optimize CCF flow estimation with different configurations. The optimization study is carried out to perform a grid search on the optimal location of the sensor pair under different flow rates. The CFD results show that the optimal sensor spacing depends on the flow rate being measured and provides guidance for sensor location implementation under various anticipated flow rates. Full article
(This article belongs to the Special Issue CFD Analysis of Nuclear Engineering)
Show Figures

Figure 1

Figure 1
<p>A general schematic of a hardware installation for CCF flow estimation [<a href="#B21-applsci-14-06687" class="html-bibr">21</a>].</p>
Full article ">Figure 2
<p>Sensor X and Sensor Y signals versus time [<a href="#B21-applsci-14-06687" class="html-bibr">21</a>].</p>
Full article ">Figure 3
<p>Computational domain used for CCF flow estimation, with fluid injection pipe, temperature sensor region, and flow direction shown.</p>
Full article ">Figure 4
<p>Computational domain, indicating the boundary conditions, including the injection fluid boundary conditions.</p>
Full article ">Figure 5
<p>One injection period for the injection pipe boundary condition in CFD simulations.</p>
Full article ">Figure 6
<p>One example of a meshing model for low-flow-rate simulation.</p>
Full article ">Figure 7
<p>Detailed meshing around the injection pipe.</p>
Full article ">Figure 8
<p>Temperature and velocity locations for the mesh sensitivity study.</p>
Full article ">Figure 9
<p>Area-weighted average temperature traces at (<b>a</b>) 0.1 m, (<b>b</b>) 0.3 m, and (<b>c</b>) 0.5 m from the inlet.</p>
Full article ">Figure 10
<p>Two local temperatures at the star-marked locations shown in <a href="#applsci-14-06687-f008" class="html-fig">Figure 8</a>.</p>
Full article ">Figure 11
<p>Area-weighted average velocity traces at (<b>a</b>) 0.1 m, (<b>b</b>) 0.3 m, and (<b>c</b>) 0.5 m from the inlet.</p>
Full article ">Figure 12
<p>Two local velocities at the star-marked locations shown in <a href="#applsci-14-06687-f008" class="html-fig">Figure 8</a>.</p>
Full article ">Figure 13
<p>One example of 3D velocity distribution of fully developed turbulent pipe flow.</p>
Full article ">Figure 14
<p>Absolute percentage errors between the meshing (area-weighted average velocity) at (<b>a</b>) 0.1 m, (<b>b</b>) 0.3 m, and (<b>c</b>) 0.5 m from the inlet.</p>
Full article ">Figure 15
<p>Absolute percentage errors of two local velocities.</p>
Full article ">Figure 16
<p><math display="inline"><semantics> <msup> <mi>u</mi> <mo>+</mo> </msup> </semantics></math> vs. <math display="inline"><semantics> <msup> <mi>y</mi> <mo>+</mo> </msup> </semantics></math> relationship based on G1, G2, and G3 meshing models.</p>
Full article ">Figure 17
<p>Temperature distribution when the target flow rate is at 178.3 GPM (highest flow rate).</p>
Full article ">Figure 18
<p>Temperature comparison under a low flow rate (∼40 GPM).</p>
Full article ">Figure 19
<p>Temperature comparison under a medium flow rate (∼133 GPM).</p>
Full article ">Figure 20
<p>Temperature comparison under a high flow rate (∼170 GPM).</p>
Full article ">Figure 21
<p>Velocity distribution under a low flow rate after water injection.</p>
Full article ">Figure 22
<p>Local flow-rate changes along the two sensor paths under a low flow rate.</p>
Full article ">Figure 23
<p>Velocity distribution under a high flow rate after water injection.</p>
Full article ">Figure 24
<p>Local flow-rate changes along the two sensor paths under a high flow rate.</p>
Full article ">Figure 25
<p>CCF flow estimation. The x-axis is the flow rate measured from the flow meter in the test facility.</p>
Full article ">Figure 26
<p>Candidate sensor locations.</p>
Full article ">Figure 27
<p>Top 10 temperature sensor pair locations for (<b>a</b>) low, (<b>b</b>) medium, and (<b>c</b>) high bulk flow rates with an 80 psi injection pressure.</p>
Full article ">Figure 28
<p>Top 10 temperature sensor pair locations for (<b>a</b>) low, (<b>b</b>) medium, and (<b>c</b>) high bulk flow rates with a 30 psi injection pressure.</p>
Full article ">Figure 29
<p>Two-dimensional heat map of the weighted performance of the sensor locations for (<b>a</b>) low, (<b>b</b>) medium, and (<b>c</b>) high bulk flow rates with an 80 psi injection pressure.</p>
Full article ">
4 pages, 1969 KiB  
Interesting Images
Detection of Hepatic Metastasis from Early Delayed Images of Modified Dual-Time-Point F-18 FDG PET/CT Images in a Patient with Breast Cancer
by Ji Young Lee and Hee-Sung Song
Diagnostics 2024, 14(15), 1653; https://doi.org/10.3390/diagnostics14151653 - 31 Jul 2024
Viewed by 337
Abstract
We present a rare case of focal F-18-2-fluoro-2-deoxyglucose (FDG) uptake in the liver observed during a modified dual-time-point F-18 FDG positron emission tomography (PET)/computed tomography (CT), so-called early delayed scanning, in a 53-year-old woman diagnosed with breast cancer. This metastatic lesion was revealed [...] Read more.
We present a rare case of focal F-18-2-fluoro-2-deoxyglucose (FDG) uptake in the liver observed during a modified dual-time-point F-18 FDG positron emission tomography (PET)/computed tomography (CT), so-called early delayed scanning, in a 53-year-old woman diagnosed with breast cancer. This metastatic lesion was revealed in 80 min delayed images after FDG injection, but not in the usual one-hour images after injection. Modified dual-time-point F-18 FDG PET/CT is convenient because compared to the 2 h delayed images of dual-time-point PET/CT, it has a shorter scanning time and avoids additional radiation exposure. Full article
(This article belongs to the Section Medical Imaging and Theranostics)
Show Figures

Figure 1

Figure 1
<p>Modified dual-time-point F-18 FDG PET/CT images on routine 60 min (<b>a</b>,<b>b</b>) and early delayed 80 min (<b>c</b>,<b>d</b>) images post-F-18 FDG injection. Focal FDG uptake is seen in S6 of the liver in early delayed images compared to 60 min images after FDG injection (white arrow).</p>
Full article ">Figure 2
<p>Axial PET images (top-to-bottom) show increased focal FDG uptake in segment 6 of the liver across consecutive slices (black arrow).</p>
Full article ">Figure 3
<p>Transverse post-gadolinium T1-weighted hepatic arterial dominant phase (<b>a</b>,<b>c</b>) and hepatic venous phase (<b>b</b>,<b>d</b>) images of MRI. Two lesions of segment 7 and segment 6 showing arterial enhancement and delayed washout are seen.</p>
Full article ">
18 pages, 1916 KiB  
Article
SF6 Tracer Technique to Estimate Methane Emission in a Dual-Flow Continuous Culture System: Test and Application
by Richard R. Lobo, Gerald Salas-Solis, Juan Vargas, Alyce Monteiro, Sarah S. da Silva, Kaliu Silva, Jose Arce-Cordero, Diwakar Vyas, Nicolas DiLorenzo, Jhones O. Sarturi and Antonio P. Faciola
Fermentation 2024, 10(8), 394; https://doi.org/10.3390/fermentation10080394 - 31 Jul 2024
Viewed by 594
Abstract
This study aimed to evaluate the sulfur hexafluoride (SF6) tracer technique for estimating methane (CH4) emissions in dual-flow continuous culture systems (DFCCS). In experiment 1 (Exp1), fermenters were filled with water, and known CH4 concentrations (0, 1.35, 2.93, [...] Read more.
This study aimed to evaluate the sulfur hexafluoride (SF6) tracer technique for estimating methane (CH4) emissions in dual-flow continuous culture systems (DFCCS). In experiment 1 (Exp1), fermenters were filled with water, and known CH4 concentrations (0, 1.35, 2.93, or 4.43 g/d) were injected using permeation tubes with SF6 release rates (3.30 or 9.65 mg/d). Headspace gas was collected using canisters, and the SF6 technique estimated CH4 recovery. Experiment 2 (Exp2) involved a DFCCS fermentation trial with ruminal fluid from three Holstein cows, testing diets with soybean meal or its partial replacement (50%) by Chlorella or Spirulina. Headspace gas was collected at intervals post-feeding. Standard curves for SF6 and CH4 quantification were inadequate for DFCCS samples, with the CH4:SF6 ratio differing from standards, indicating the data needs further SF6 release rate evaluation. In Exp1, a high correlation (r = 0.97) was found between infused and calculated CH4, indicating good repeatability. Low and high SF6 rates performed similarly at low CH4 infusion, but high SF6 overestimated CH4 at high infusion. Exp2 showed CH4 emissions irrespective of SF6 rate and indicated reduced CH4 emissions and increased NDF degradation with algae-containing diets. Further evaluation of the SF6 tracer technique is warranted for DFCCS. Full article
(This article belongs to the Special Issue In Vitro Digestibility and Ruminal Fermentation Profile, 2nd Edition)
Show Figures

Figure 1

Figure 1
<p>Schematic representation of CH<sub>4</sub> infusion system. A—the central gas regulator that is responsible for the regulation of CH<sub>4</sub> infusion from the gas cylinder to the central pipe, B—the central pipe connects the gas regulator to each connecting pipe, C—2-way flow control valves responsible for the fine adjustments of CH<sub>4</sub> flow into each fermenter, and D—individual connecting pipes that conduct CH<sub>4</sub> flow from the central pipes into each fermenter. Fermenters were divided into two groups (main plots) before the first period (P1), and each group of fermenters received contrasting SF<sub>6</sub> release rates. In the second period (P2) a treatment crossover of contrasting SF<sub>6</sub> release rates was carried out.</p>
Full article ">Figure 2
<p>Distribution of the relative final pressure of the canisters during experiments 1 (n = 48) and 2 (n = 16). The X-axis represents the distribution of the relative final pressure of canisters. The Y-axis represents the number of observations.</p>
Full article ">Figure 3
<p>Schematic representation of the Department of Animal Sciences, University of Florida, dual-flow continuous culture system. A—liquid outflow effluent that passes through the 1 mm pore-size stainless steel mesh is pumped out of the fermenter by a peristaltic pump and stored into a container immersed in a cold-water bath; B—liquid and solid particles that are not pumped out by the peristaltic pump can leave the fermenters by flowing out through the solid outflow; C—gas generator pumps nitrogen gas into the fermenters (headspace and liquid phase) to keep the anaerobiosis within the fermenters; D—artificial saliva is stored in a container and is pumped into the fermenters at a rate of 3 mL/min; E—opening for feeding of the fermenters; F—opening for additional collections, for instance, this opening was used for collection of headspace gas sample during experiment 2; G—base of the fermenter that contains the temperature controller and is responsible for the temperature maintenance, in additional, a magnetic stirrer device is located in the base of the fermenter, which propels the central mixer (H) at a set rotation.</p>
Full article ">Figure 4
<p>CH<sub>4</sub> and SF<sub>6</sub> analyses for experiment 1. At the top left of the graphics is presented equation and R<sup>2</sup> for the standard curve; in addition, the Y-axis is the area under the curve (AUC) used to estimate CH<sub>4</sub> and SF<sub>6</sub> concentrations. Solid circles (●) represent the observations for the standard curve, and the dashed line is the fitted standard curve. Open squares (<span style="color:red">□</span>) represent the samples from the low SF<sub>6</sub> release rate, and open triangles (<span style="color:red">Δ</span>) represent the samples from the high SF<sub>6</sub> release rate.</p>
Full article ">Figure 5
<p>CH<sub>4</sub> and SF<sub>6</sub> analyses for experiment 2. At the top left of the graphics is presented equation and R<sup>2</sup> for the standard curve; in addition, the Y-axis is the area under the curve (AUC) used to estimate CH<sub>4</sub> and SF<sub>6</sub> concentrations. Solid circles (●) represent the observations for the standard curve, and the dashed line is the fitted standard curve. Open squares (<span style="color:red">□</span>) represent the samples from the low SF<sub>6</sub> release rate, and open triangles (<span style="color:red">Δ</span>) represent the samples from the high SF<sub>6</sub> release rate.</p>
Full article ">Figure 6
<p>Pearson correlation analysis between CH<sub>4</sub> infused and estimated by the SF<sub>6</sub> tracer technique (n = 36 observations). Triangle, diamond, and circles represent CH<sub>4</sub> infused between 0.93–1.61, 2.06–3.41, and 3.88–4.82 g/d, respectively.</p>
Full article ">Figure 7
<p>Effects of interaction between CH<sub>4</sub> and SF<sub>6</sub> release on the estimation of CH<sub>4</sub> recovery (g/d) and concentration of SF<sub>6</sub> (mg/L). Solid triangles (▲) and circles (●) represent low and high SF6 release, respectively, in experiment 1.</p>
Full article ">Figure 8
<p>Effects of SF<sub>6</sub> release and partial replacement of soybean meal (control) with <span class="html-italic">Chlorella</span> or <span class="html-italic">Spirulina</span> in CH<sub>4</sub> production (<b>A</b>) and concentration of SF<sub>6</sub> (<b>B</b>) in the sample.</p>
Full article ">
8 pages, 235 KiB  
Article
Efficacy of Urethral Sphincter Botulinum Toxin A Injection in Patients with Spinal Cord Injury with Dysuria: A Retrospective Cohort Study
by Wan-Ru Yu, Jing-Hui Tian and Hann-Chorng Kuo
Toxins 2024, 16(8), 336; https://doi.org/10.3390/toxins16080336 - 31 Jul 2024
Viewed by 397
Abstract
Spinal cord injury (SCI) often leads to neurogenic lower urinary tract dysfunction, causing dysuria and affecting patients’ well-being. This study aimed to evaluate the efficacy of a urethral sphincter botulinum toxin A (BoNT-A) injection in patients with SCI and dysuria. This was a [...] Read more.
Spinal cord injury (SCI) often leads to neurogenic lower urinary tract dysfunction, causing dysuria and affecting patients’ well-being. This study aimed to evaluate the efficacy of a urethral sphincter botulinum toxin A (BoNT-A) injection in patients with SCI and dysuria. This was a retrospective study including 118 patients with SCI who underwent a urethral BoNT-A injection following a standardized protocol for refractory voiding dysfunction. The protocol involved injecting BoNT-A into the urethral sphincter under cystoscopic guidance. Patient demographics, bladder condition parameters, and treatment outcomes were analyzed. Logistic regression and receiver operating characteristic curve analyses were performed to identify predictors of treatment success. Of the 118 patients, 71 (60.1%) showed satisfactory treatment outcomes after the injection. Post-injection status, bladder management, and injection frequency varied significantly among patients with satisfactory and unsatisfactory treatment outcomes. Age, bladder compliance, intravesical pressure, and bladder contractility were indicators of satisfactory outcomes. The first sensation of bladder filling of ≤263 mL, intravesical pressure of ≤28, and bladder contractility index of ≥14 were highly correlated with satisfactory outcomes. A urethral sphincter BoNT-A injection shows promise in managing dysuria in patients with SCI. Understanding bladder condition parameters and patient demographics helps optimize patient selection for this intervention. Further studies are needed to validate these findings and refine treatment protocols. Full article
6 pages, 187 KiB  
Brief Report
Comparison of Single-Treatment Efficacy of Bevacizumab and Ranibizumab for Retinopathy of Prematurity
by Fumio Takano, Kaori Ueda, Yuko Yamada-Nakanishi and Makoto Nakamura
Children 2024, 11(8), 927; https://doi.org/10.3390/children11080927 - 31 Jul 2024
Viewed by 283
Abstract
Background: Retinopathy of prematurity (ROP) is a significant cause of blindness in infants. Appropriate therapeutic intervention is essential because retinal detachment due to the progression of ROP is critical to visual function. The intravitreal injection of anti-vascular endothelial growth factor (VEGF) agents has [...] Read more.
Background: Retinopathy of prematurity (ROP) is a significant cause of blindness in infants. Appropriate therapeutic intervention is essential because retinal detachment due to the progression of ROP is critical to visual function. The intravitreal injection of anti-vascular endothelial growth factor (VEGF) agents has been increasingly applied to inhibit the development and progression of ROP. In this study, we compared the efficacy of single intravitreal bevacizumab (IVB) and ranibizumab (IVR) injections for the treatment of ROP. Methods: A total of 39 eyes in 21 patients with severe ROP and IVB (15 eyes of 8 patients) and IVR (24 eyes of 13 patients) were retrospectively reviewed. Patient background, the severity of ROP, and the percentage of cases in which ROP regressed without additional treatment were compared between the two groups. Results: Patient background and ROP severity were not significantly different between the two groups. Recurrence was observed in one eye of one patient in the IVB group, and thirteen eyes in seven patients in the IVR group required additional laser photocoagulation, which was significantly different in the two groups (p < 0.01, Fisher’s exact test). In the IVR group, two eyes of two patients underwent vitreous surgery. Conclusion: Compared with IVR, IVB is likely to control the severity of ROP with a single treatment. Full article
14 pages, 8153 KiB  
Article
Customization of Computed Tomography Radio-Opacity in 3D-Printed Contrast-Injectable Tumor Phantoms
by Yuktesh Kalidindi, Aravinda Krishna Ganapathy, Liam Cunningham, Adriene Lovato, Brian Albers, Anup S. Shetty and David H. Ballard
Micromachines 2024, 15(8), 992; https://doi.org/10.3390/mi15080992 - 31 Jul 2024
Viewed by 378
Abstract
Medical Imaging Phantoms (MIPs) calibrate imaging devices, train medical professionals, and can help procedural planning. Traditional MIPs are costly and limited in customization. Additive manufacturing allows for customizable, patient-specific phantoms. This study examines the CT attenuation characteristics of contrast-injectable, chambered 3D-printed phantoms to [...] Read more.
Medical Imaging Phantoms (MIPs) calibrate imaging devices, train medical professionals, and can help procedural planning. Traditional MIPs are costly and limited in customization. Additive manufacturing allows for customizable, patient-specific phantoms. This study examines the CT attenuation characteristics of contrast-injectable, chambered 3D-printed phantoms to optimize tissue-mimicking capabilities. A MIP was constructed from a CT of a complex pelvic tumor near the iliac bifurcation. A 3D reconstruction of these structures composed of three chambers (aorta, inferior vena cava, tumor) with ports for contrast injection was 3D printed. Desired attenuations were 200 HU (arterial I), 150 HU (venous I), 40 HU (tumor I), 150 HU (arterial II), 90 HU (venous II), and 400 HU (tumor II). Solutions of Optiray 350 and water were injected, and the phantom was scanned on CT. Attenuations were measured using ROIs. Mean attenuation for the six phases was as follows: 37.49 HU for tumor I, 200.50 HU for venous I, 227.92 HU for arterial I, 326.20 HU for tumor II, 91.32 HU for venous II, and 132.08 HU for arterial II. Although the percent differences between observed and goal attenuation were high, the observed relative HU differences between phases were similar to goal HU differences. The observed attenuations reflected the relative concentrations of contrast solutions used, exhibiting a strong positive correlation with contrast concentration. The contrast-injectable tumor phantom exhibited a useful physiologic range of attenuation values, enabling the modification of tissue-mimicking 3D-printed phantoms even after the manufacturing process. Full article
Show Figures

Figure 1

Figure 1
<p>Illustration of the chambered 3D-printed tumor phantom manufacturing process.</p>
Full article ">Figure 2
<p>Depiction of the tumor phantom. (<b>A</b>) 3D reconstruction with three separate models. (<b>B</b>) CAD model with Luer Locks indicated by red arrows. (<b>C</b>) STL model in Preform 3.34.2 slicer software with supports. (<b>D</b>) Final 3D-printed tumor phantom on CT gantry. (<b>E</b>) CAD model of tumor phantom with rulers visible in decimeters (dm).</p>
Full article ">Figure 3
<p>Depiction of the inside of all tumor phantom hollow chambers after support removal. This version of the tumor phantom provides views of (<b>A</b>) the tumor chamber interior, (<b>B</b>) the arterial chamber interior indicated by red arrows, and (<b>C</b>) the venous chamber interior indicated by the black arrow. (<b>D</b>) Axial view of the chamber-exposed version of the 3D-printed tumor phantom.</p>
Full article ">Figure 4
<p>CT images of all six phases of tumor phantom in axial, coronal, and sagittal planes along with ROI placement by Rater 1 in each image depicted by colored circles.</p>
Full article ">Figure 5
<p>CT images of tumor phantom arterial phase I in (<b>A</b>) axial, (<b>B</b>) coronal, and (<b>C</b>) sagittal planes with ROI placement (colored circles) and depiction of attenuation measurement.</p>
Full article ">Figure 6
<p>(<b>A</b>) Coronal CT image of contrast solution syringe gantry arrangement with concentration expressed as <span class="html-italic">v</span>/<span class="html-italic">v</span> percentage. (<b>B</b>) ROI placement within each syringe. (<b>C</b>) ROI placement for 3.61% and 2.44% contrast solution syringes shown with colored circles and corresponding labels with attenuation measurements.</p>
Full article ">Figure 7
<p>Tumor phantom and syringe attenuation (HU) graphed against contrast solution concentration utilized for each phase represented using volume/volume percentage (%).</p>
Full article ">Figure 8
<p>ICC interrater analysis of both readers for tumor phantom and syringe attenuations.</p>
Full article ">
12 pages, 6598 KiB  
Hypothesis
Role of Oncostatin M in Exercise-Induced Breast Cancer Prevention
by Kara A. Negrini, Dan Lin, Dhruvil Shah, Hongke Wu, Katherine M. Wehrung, Henry J. Thompson, Tiffany Whitcomb and Kathleen M. Sturgeon
Cancers 2024, 16(15), 2716; https://doi.org/10.3390/cancers16152716 - 31 Jul 2024
Viewed by 436
Abstract
Moderate-to-vigorous-intensity physical activity decreases the risk of breast cancer. The muscle-derived cytokine (myokine), oncostatin M (OSM), has been shown to decrease breast cancer cell proliferation. We hypothesized that OSM is involved in physical activity-induced breast cancer prevention, and that OSM antibody (Anti-OSM) administration [...] Read more.
Moderate-to-vigorous-intensity physical activity decreases the risk of breast cancer. The muscle-derived cytokine (myokine), oncostatin M (OSM), has been shown to decrease breast cancer cell proliferation. We hypothesized that OSM is involved in physical activity-induced breast cancer prevention, and that OSM antibody (Anti-OSM) administration would mitigate the effect of physical activity in a rat model of mammary carcinoma. Female Sprague Dawley rats were injected with 50 mg/kg N-methyl-N-nitrosourea to induce mammary carcinogenesis. During the 20-week study, rats were exercise trained (EX) or remained sedentary (SED). Additional groups were treated with Anti-OSM antibody (SED + Anti-OSM and EX + Anti-OSM) to explore the impact of OSM blockade on tumor latency. Exercise training consisted of treadmill acclimation and progressive increases in session duration, speed, and grade, until reaching 30 min/day, 20 m/min at 15% incline. Experimentally naïve, age-matched, female rats also completed an acute exercise test (AET) with time course blood draws to evaluate OSM plasma concentrations. Relative tumor-free survival time was significantly longer in EX animals (1.36 ± 0.39) compared to SED animals (1.00 ± 0.17; p = 0.009), SED + Anti-OSM animals (0.90 ± 0.23; p = 0.019), and EX + Anti-OSM animals (0.93 ± 0.74; p = 0.004). There were no significant differences in relative tumor latency between SED, SED + Anti-OSM, or EX + Anti-OSM animals. Following the AET, OSM plasma levels trended higher compared to baseline OSM levels (p = 0.080). In conclusion, we observed that exercise-induced delay of mammary tumor development was mitigated through Anti-OSM administration. Thus, future studies of the OSM mechanism are required to lay the groundwork for developing novel chemo-prevention strategies in women who are unable or unwilling to exercise. Full article
(This article belongs to the Special Issue Lifestyle Choices and Endocrine Dysfunction on Cancer Onset and Risk)
Show Figures

Figure 1

Figure 1
<p>Schematic of the experimental timeline. All rats were acclimated to the treadmill prior to randomization into experimental groups. After treadmill ramp up, exercised rats continued training 5 days per week for the duration of this study (week 3–20). MNU = n-methyl-n-nitrosourea. Anti-OSM = Mouse anti-oncostatin M.</p>
Full article ">Figure 2
<p>(<b>A</b>) Rat body weight growth curve over 20 weeks. Week 0 = pre-MNU injection weight. All SED + Anti-OSM rats were euthanized by week 14 due to tumor burden reaching 4 cm<sup>3</sup>. The drop in average SED weights during weeks 19 and 20 was due to a decrease in animal numbers from tumor burden reaching 4 cm<sup>3</sup> (SED <span class="html-italic">n</span> = 2 at week 19). No statistical significance. (<b>B</b>) Average heart weight to carcass weight ratio. SED <span class="html-italic">n</span> = 15, EX <span class="html-italic">n</span> = 14, SED + Anti-OSM <span class="html-italic">n</span> = 5, EX + Anti-OSM <span class="html-italic">n</span> = 12. No statistical significance. x = group mean.</p>
Full article ">Figure 3
<p>Representative photos of malignant tumors from each group. (<b>A</b>) SED. (<b>B</b>) EX. (<b>C</b>) SED + Anti-OSM. (<b>D</b>) EX + Anti-OSM. All scale bars represent 1 cm.</p>
Full article ">Figure 4
<p>Average normalized tumor latency across groups (SED <span class="html-italic">n</span> = 14, EX <span class="html-italic">n</span> = 14, SED + Anti-OSM <span class="html-italic">n</span> = 5, EX + Anti-OSM <span class="html-italic">n</span> = 10). * <span class="html-italic">p</span> &lt; 0.05, † <span class="html-italic">p</span> &lt; 0.01. x = group mean.</p>
Full article ">Figure 5
<p>Plasma OSM concentrations after 1 h of exercise on motorized treadmill. OSM was measured from plasma samples isolated from blood collected at three different timepoints (before, immediately after, and 2 h after) from experimentally naïve rats (<span class="html-italic">n</span> = 7). **: <span class="html-italic">p</span> = 0.080.</p>
Full article ">
Back to TopTop